Trusted Information for Healthy Pregnancies
Archive for November 30, 2009
Plastics Chemical Phthalate May Lead to Preterm Birth
Nov 30th
Pregnant women who are exposed to higher levels of an increasingly controversial chemical in certain plastics may deliver their babies slightly earlier than women with less exposure, results of a study suggest.
The chemical, DEHP - short for di(2-ethylhexyl)phthalate - is a "plasticizer" used widely in consumer products to help make vinyl plastic soft and flexible.
"Exposures (to DEHP) are ubiquitous," Dr. Robin M. Whyatt from Columbia Center for Children's Environmental Health in New York City told Reuters Health. DEHP breakdown products "have been detected in 95% of the general U.S. population."
In recent preliminary studies, DEHP exposure has been linked to some health risks. In animal studies, for example, exposure to this and other so-called phthalates has been linked to lower-weight babies and shorter pregnancies.
In preliminary human studies, prenatal DEHP exposure has been shown to affect the timing of labor; however, the findings have been mixed.
They gauged DEHP exposure by measuring four DEHP breakdown products in urine samples collected from the 311 African American or Dominican women aged 18 to 35. All of the women were living in New York City and were in their third trimesters.
The team found that the higher the level of DEHP breakdown products in the mothers' urine during pregnancy, the earlier the infant was born, Whyatt told Reuters Health. Babies with the highest level of exposure were born about five days earlier than those exposed to the lowest levels.
It's important to note, the researchers say, that the women in the study delivered their babies at or near term. However, if prenatal DEHP exposure were to lead to more infants being delivered prematurely, on average, this could be cause for concern.
Steve Risotto, Senior Director, Phthalate Esters, at the American Chemistry Council industry group, noted that two earlier studies contradicted the current one, showing opposite effects. "There was also no association found between phthalate exposure and prematurity, as all of the births were full term," he told Reuters Health.
Source
Alyson Hannigan’s Homebirth Story Available for Viewing
Nov 30th
The first two installments of Alyson Hannigan's birth story are now available for viewing. Hear how she and her husband decided on a homebirth and listen to Alyson describe her first signs of labor.
Many Pregnant Women Take Drugs Harmful to Baby
Nov 30th
With the help of their doctors, women planning to become pregnant should take an inventory of the medications they take, researchers from Canada advise.
In a study, they found that many pregnant women still take medications long known to cause birth defects.
Some medications with known fetal risk, such as drugs that control epilepsy, are essential during pregnancy, Dr. Anick Berard, at the University of Montreal in Quebec, noted in an email correspondence to Reuters Health.
Other medications, such as those that treat severe acne, anxiety and psychiatric drugs, antibiotics, and many drugs prescribed for heart disease and medical conditions, "can and should be avoided," according to Berard.
Women should understand the side effects of any drug they are taking -- especially drugs treating a chronic condition -- and plan pregnancies to avoid or minimize risks such drugs pose to babies, Berard added.
For the 5 years between January 1998 and the last day of 2002, Berard and colleagues analyzed the prescriptions filled by pregnant women for drugs available at the time and known to pose fetal risks.
Their report, in BJOG: An International Journal of Obstetrics and Gynecology, shows 56 percent of 109,344 pregnant women filled at least one medication prescription. A total of 6.3 percent (6,871 women) did so for at least one medication known to pose a risk to the fetus.
"These pregnancies were associated with an elevated number of (pregnancy terminations) and babies born with major (birth defects) in comparison with the expected numbers in the population," they note.
Specifically, terminations occurred in 47 percent of the pregnancies exposed to drugs with known fetal risks. Six percent of these pregnancies ended in miscarriage.
By contrast, in the much larger non-exposed group about 36 percent of the pregnancies had been terminated and fewer than 5 percent ended in miscarriage.
Berard's team further identified birth defects in 8.2 percent of 2,842 infants exposed to risky drugs during gestation and available for assessment, compared with 7.1 percent of the 59,287 infants not exposed. This is "a statistically significant difference," they note.
They emphasize, however, that it cannot be concluded that the drug exposure caused the birth defects. These pregnancies may have also been exposed to other harmful agents or maternal health conditions, they point out.
Source